Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial was for people with diffuse large B cell lymphoma (DLBCL) that had continued to grow or came back after chemotherapy.
Recruitment start: 28 September 2011
Recruitment end: 17 October 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Chris Hatton
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
NIHR Oxford Biomedical Research Centre
Oxford University Hospitals NHS Trust
Last reviewed: 26 Apr 2016
CRUK internal database number: 7822
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
